Clinical Trial Update: A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old. [Phase 4]

View source ↗

Summary

Pfizer's COMIRNATY COVID-19 vaccine is being studied in people under 21 to monitor safety in relation to myocarditis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocarditis

Drugs mentioned

• Comirnaty (tozinameran)

Snippet

Sponsor: Pfizer | Conditions: Myocarditis | Phase 4 | Status: RECRUITING